Eurofins Scientific SE logo

Eurofins Scientific SE

ERFSF US

Eurofins Scientific SEUSUnited States Composite

60.23

USD
+1.08
(+1.83%)

Company Description

CEO
Dr. Gilles G. Martin Ph.D.
Full Time Employees
61,798
Sector
Healthcare
Industry
Diagnostics & Research
Address
23 Val Fleuri Luxembourg City Luxembourg 1526
Business
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Company News

  • Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2024

  • The Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLC

  • Eurofins: Purchases of Own Shares from the 18th to the 22th of March 2024

  • Eurofins: Convening Notice of the Shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting of the Company Valid as an Information Notice for the Bondholders

  • Eurofins: Purchases of Own Shares From the 11th to the 15th of March 2024

  • Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 29 February 2024

  • Eurofins: Purchases of Own Shares From the 5th to the 8th of March 2024

  • EUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?

  • EUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?

  • Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets

  • Eurofins E&E and ETS-Lindgren Complete Half-Million-Dollar Expansion to Silicon Valley EMC Testing Facility

  • Eurofins Delivers Strong Margin Improvement and Cash Generation in H2 2023 and Annual Results in Line With Its 2023 Objectives. Remains Confident to Achieve Its 2027 Objectives.

  • Eurofins MET Labs Recognized for Instrumental Support in Intuitive Machines’ IM-1 Lunar Mission

  • Eurofins: Purchases of Own Shares from the 12th to the 14th of February 2024

  • Eurofins Scientific SE: Purchases of Own Shares from the 5th to the 9th of February 2024

  • Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2024

  • Eurofins: Purchases of Own Shares From the 29th of January to the 2nd of February 2024

  • Eurofins Environment Testing in Sacramento, CA in Partnership with EPA Region 10 and EPA’s Office of Water Published Draft Method 1634, an Analytical Procedure to Test for 6PPD-Quinone in Surface and Stormwater

  • Eurofins: Purchases of Own Shares From the 22th of January to the 26th of January 2024

  • Eurofins: Purchases of Own Shares From the 15th of January to the 19 of January 2024